By
Bijoyeta Das
Published: March 6, 2014, 7:43 p.m.·
Tags:
HIV coinfection,
Global TB response,
Access,
Drug-resistant TB,
TB programs
TB remains the deadliest infectious disease in the country with two deaths every three minutes.
Read More →
By
Global Coalition of TB Activists
Published: March 3, 2014, 11:11 p.m.·
Tags:
Advocacy
The Global Coalition of TB Activists (GCTA) is encouraging and accepting applications from individuals as well as non-individuals. Deadline extended to March 14.
Read More →
By
Médecins Sans Frontières
Published: March 1, 2014, 5:46 p.m.·
Tags:
Advocacy,
Access
Tuberculosis patients are unable to receive their lifesaving medicine, including drug-resistant tuberculosis patients.
Read More →
By
GroundUp
Published: March 1, 2014, 5:14 p.m.·
Tags:
Advocacy
The project has been scrapped after the Treatment Action Campaign asked the national government to intervene.
Read More →
By
CORE Group,
International Union Against Tuberculosis and Lung Disease
Published: Feb. 26, 2014, 4:32 p.m.·
Tags:
Pediatrics,
Advocacy,
TB programs,
Global TB response
The document outlines community-based strategies for integrating childhood TB activities with other maternal and child health care services through existing diagnosis and management algorithms.
Read More →
By
Aeras
Published: Feb. 19, 2014, 11:10 p.m.·
Tags:
Mining sector,
Research and development,
Advocacy
Tell the Southern African Development Community nations to prioritize TB R&D. Sign the petition.
Read More →
By
ERS/WHO TB Consilium
Published: Feb. 19, 2014, 1:21 p.m.·
Tags:
Treatment,
Drug-resistant TB,
HIV coinfection
If are you a physician dealing with complex M/XDR-TB, TB/HIV and other difficult-to-treat TB cases, the ERS/WHO TB Consilium can help you to manage them, free of charge.
Read More →
By
TB CAB,
Community Research Advisors Group (CRAG),
Treatment Action Group
Published: Feb. 13, 2014, 12:54 p.m.·
Tags:
Advocacy,
Pharma industry,
Research and development
Community groups express concern for AstraZeneca's departure from tuberculosis and urge the company to ensure continued investment in the field.
Read More →
By
TB CAB,
Treatment Action Group
Published: Feb. 7, 2014, 3:30 p.m.·
Tags:
HIV coinfection,
Treatment,
Drug-resistant TB,
Advocacy
Comment on Guidance for industry on pulmonary tuberculosis: Developing drugs for treatment.
Read More →
Page 100 of 133 · Total posts: 10
←First
99
100
101
Last→